Keyphrases
Left Ventricular Noncompaction
100%
Kawasaki Disease
36%
Gene Variants
32%
Dilated Cardiomyopathy
25%
Sarcomere Genes
24%
Next-generation Sequencing
23%
Clinical Significance
22%
Systematic Meta-analysis
21%
Pediatric Patients
19%
Congestive Heart Failure
19%
Cardiomyopathy
16%
Meta-analysis
15%
Pathogenic Variants
13%
Genotype-phenotype Correlation
13%
Coronary Artery Lesions
12%
Heart Failure
11%
Genetic Variants
11%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
11%
Echocardiographic
11%
Fetal Onset
11%
Congenital Heart Disease
11%
Juvenile Type
10%
MicroRNA-93
10%
T-box
10%
TBX5
10%
Ion Channel Genes
10%
Left Ventricular Non-compaction Cardiomyopathy
10%
Hypertensive Hydrocephalus
10%
Pediatric Case Report
10%
Tafazzin
10%
Multidetector Computed Tomography
10%
MicroRNA-145-5p
10%
Endothelial Microparticles
10%
MicroRNA-320a
10%
Chronic Myocarditis
10%
Tetralogy of Fallot
10%
Long-term Prognosis
10%
Variant Phenotypes
10%
Vascular Endothelial Growth Factor
10%
Peripheral Blood Mononuclear Cells
10%
Anomalous Origin of Right Coronary Artery
10%
Delayed Onset
10%
Adenosine Deaminase Deficiency
10%
Vasculitis
10%
Acute Disseminated Encephalomyelitis
10%
Reoperation
10%
Early Infancy
10%
Trabeculation
10%
MYH7
9%
N-terminal pro-BNP
9%
Medicine and Dentistry
Noncompaction Cardiomyopathy
78%
Congestive Heart Failure
36%
Myocardial Disease
20%
Next Generation Sequencing
19%
Sarcomere
17%
Dilated Cardiomyopathy
17%
Persistent Truncus Arteriosus
15%
Pediatrics Patient
15%
Infancy
13%
Brain Natriuretic Peptide
13%
Amino Terminal Sequence
13%
MYH7
12%
Hydrocephalus
10%
Pediatrics
10%
Tafazzin
10%
Tetralogy of Fallot
10%
Right Coronary Artery
10%
Multidetector Computed Tomography
10%
Genotype Phenotype Correlation
10%
Reoperation
10%
Heart Function
10%
Cardiac Dysrhythmia
8%
Hypoplasia
7%
Clinical Feature
6%
Systolic Function
6%
Beta Adrenergic Receptor Blocking Agent
5%
Diastolic Function
5%
Pooled Analysis
5%
Gestational Diabetes
5%
Kawasaki Disease
5%
Neonate
5%
Systematic Review
5%
Coronary Occlusion
5%
Ejection Fraction
5%
Adverse Event
5%
Magnetic Resonance Imaging
5%
Left Ventricular Hypertrophy
5%
Gadolinium
5%
Tachycardia-Induced Cardiomyopathy
5%
Lung Congestion
5%
